INSIGHTS ON CLINICAL TRIAL DESIGN
-
![90016_JUDI_Pinball_Animation]( "Keeping Your Trials In Motion And Use AI Where It Makes Sense")
Keeping Your Trials In Motion And Use AI Where It Makes SenseExplore the "pinball" approach used by the Judi platform that is giving stakeholders a distinct competitive advantage in the clinical trial landscape.
-
![Cancer patient consulting with doctor-GettyImages-1217056000]( "Solutions To The Challenges Of Oncology Trials")
Solutions To The Challenges Of Oncology TrialsThis significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.
-
![clinical-trial-study-design-GettyImages-2215843204]( "Raising The Bar For Central Lab Logistics")
Raising The Bar For Central Lab LogisticsModernizing clinical trial supply chains requires proactive, technology-driven oversight to protect sample integrity, enhance resilience, navigate regulations, and support sustainability.
-
![GettyImages-2154021980-trial-payment-card-cost]( "Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial?")
Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial?Site payment models shape trial cost and execution. Compare visit‑based simplicity vs procedure‑level precision to see when flexibility and savings beat complexity — or when predictability wins.
-
Clinical Trial Participants Say It's One Of Their Biggest Burdens11/2/2026
Travel to the study site shapes who enrolls, who stays compliant, and who completes a trial. Participant survey data shows where distance creates friction and which supports matter most.
-
Beyond Automation: Transforming Clinical Trial Delivery Through Structured Information10/23/2026
Study build delays stem less from slow tasks than from protocol intent being reinterpreted at every handoff. Treating the protocol as structured, reusable information changes where AI and expertise belong.
-
Why Clinical Trial Demographics Don't Match Real-World Populations12/4/2025
Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.
-
Accelerating Oncology Drug Development Through Innovative Designs3/30/2026
Adaptive and novel trial designs are redefining oncology development, powering faster decisions with smarter flexibility. Discover innovative approaches that elevate efficiency while safeguarding scientific rigor.
-
Overcoming Barriers To Participation11/22/2024
Explore effective strategies to enhance diversity and inclusion in clinical trials by supporting underrepresented patient groups, ensuring equitable health outcomes and broader representation.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1311429557-vaccine-shot]( "The #1 Rated Leader In DCT Now Offers The Vaccine Pathway")
Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.
-
![GettyImages-1141567619 doctor patient]( "First In Human (FIH) Fact Sheet")
Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.
-
![Clinical Trials]( "TrialScope Disclose")
With TrialScope Disclose, study sponsors streamline and optimize the entire clinical trial disclosure process from initial registration to final results — mitigating risk, maximizing transparency and ultimately moving healthcare forward.
-
![GettyImages-1054148730-clinical-outsourcing-partner-FSP]( "What Does 'Powered By Block Clinical' Mean?")
Join us in supporting every part of the clinical trial ecosystem — patients, caregivers, sites, and suppliers — to ensure trials run safely, efficiently, and successfully.
-
![clinical-trials-patients-GettyImages-1629549075]( "Develop Site-Centric Protocols To Optimize Enrollment")
Optimize clinical trial protocols by aligning scientific goals with real-world site operations. Improve enrollment, reduce site burden, and minimize costly amendments through data-driven design.
